{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:00:19Z","timestamp":1761181219487,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jbspin.2019.01.022","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T07:47:53Z","timestamp":1549784873000},"page":"615-619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study"],"prefix":"10.1016","volume":"86","author":[{"given":"Jasvinder A.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Cleveland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.01.022_bib0005","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","article-title":"Sjogren's syndrome","volume":"366","author":"Fox","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0010","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1136\/annrheumdis-2014-205375","article-title":"Epidemiology of primary Sjogren's syndrome: a systematic review and meta-analysis","volume":"74","author":"Qin","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0020","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/art.1780220113","article-title":"Coexistent gout and rheumatoid arthritis. Case report and literature review","volume":"22","author":"Wallace","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0025","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jaut.2017.02.006","article-title":"Mitochondrial DNA oxidation induces imbalanced activity of NLRP3\/NLRP6 inflammasomes by activation of caspase-8 and BRCC36 in dry eye","volume":"80","author":"Chi","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.exer.2015.02.013","article-title":"Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients","volume":"134","author":"Zheng","year":"2015","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0035","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.152.11.5532","article-title":"Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome","volume":"152","author":"Fox","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/ard.62.4.359","article-title":"Interleukin 1beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjogren's syndrome","volume":"62","author":"Willeke","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0045","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jamaophthalmol.2013.195","article-title":"Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial","volume":"131","author":"Amparo","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0050","doi-asserted-by":"crossref","first-page":"e30123","DOI":"10.1371\/journal.pone.0030123","article-title":"Interleukin-1 inhibition and fatigue in primary Sjogren's syndrome--a double blind, randomised clinical trial","volume":"7","author":"Norheim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0055","unstructured":"U.S. Census Bureau. National Population Projections. I. Summary files. Total population by age, sex, race and Hispanic origin. (NP-T4-F). Projections of the total resident population by 5-year age groups, race and Hispanic origin with special age categories: middle series. 2025 to 2045; 2000. Available from: https:\/\/www2.census.gov\/programs-surveys\/popproj\/tables\/2000\/2000-national-summary-tables\/np-t4-f.pdf. [Accessed 01\/18\/2018 2018]."},{"key":"10.1016\/j.jbspin.2019.01.022_bib0060","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.3899\/jrheum.101149","article-title":"The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases","volume":"38","author":"Bernatsky","year":"2011","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0065","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.22767","article-title":"Quality of care for gout in the US needs improvement","volume":"57","author":"Singh","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12891-015-0614-2","article-title":"Validity of gout diagnosis in Swedish primary and secondary care - a validation study","volume":"16","author":"Dehlin","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0075","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives","volume":"46","author":"Romano","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2017.09.019","article-title":"Enhanced expression of NLRP3 inflammasome-related inflammation in peripheral blood mononuclear cells in Sjogren's syndrome","volume":"474","author":"Kim","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0085","doi-asserted-by":"crossref","first-page":"e0126277","DOI":"10.1371\/journal.pone.0126277","article-title":"Upregulation of NLRP3 inflammasome in the tears and ocular surface of dry eye patients","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2249.1996.d01-824.x","article-title":"IL-1 receptor antagonist in saliva; characterization in normal saliva and reduced concentration in Sjogren's syndrome (SS)","volume":"106","author":"Dubost","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0095","first-page":"720","article-title":"Polymorphisms of IL-1 beta gene in Japanese patients with Sjogren's syndrome and systemic lupus erythematosus","volume":"31","author":"Muraki","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.01.022_bib0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1592\/phco.28.4.437","article-title":"Comparison of drug adherence rates among patients with seven different medical conditions","volume":"28","author":"Briesacher","year":"2008","journal-title":"Pharmacotherapy"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:25:44Z","timestamp":1761150344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X19300193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1297319X19300193"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.022","relation":{},"ISSN":["1297-319X"],"issn-type":[{"type":"print","value":"1297-319X"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of Sjogren's syndrome in the older adults with gout: A medicare claims study","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.","name":"copyright","label":"Copyright"}]}}